Fresenius Kidney Care Executive and Leadership Team

David Cameron, the Chief Executive Officer at Fresenius Kidney Care, directs the overarching strategic vision for the organization. This leadership role involves managing the expansion of outpatient dialysis services across the United States to ensure patients receive consistent, high-quality care. By aligning clinical excellence with operational efficiency, the Chief Executive Officer drives the company toward sustainable growth within the competitive renal health market. David Cameron maintains close collaboration with the Board to refine long-term objectives and address evolving healthcare regulations. Through rigorous oversight of clinical standards, the Chief Executive Officer ensures that every facility meets the complex needs of the patient population. This executive leadership fosters a culture of innovation, prioritizing advancements in treatment modalities that improve patient longevity. Ultimately, the Chief Executive Officer secures the market position of the organization by balancing fiscal responsibility with the mission of providing life-sustaining dialysis services to communities nationwide.

Surasak Kitseree, the Chief Financial Officer at Fresenius Kidney Care, manages the financial health and capital allocation strategies for the organization. This role involves overseeing the budgeting processes for outpatient centers to ensure resources support high-quality dialysis delivery. By analyzing market trends and operational costs, the Chief Financial Officer optimizes the financial performance of the company. Surasak Kitseree works alongside the executive team to evaluate investment opportunities in new medical technologies and facility infrastructure. This leadership position requires precise management of revenue cycles and cost-containment initiatives to maintain profitability while expanding access to care. Through detailed financial reporting, the Chief Financial Officer provides the transparency necessary for informed decision-making at the board level. By mitigating financial risks and ensuring regulatory compliance, the Chief Financial Officer strengthens the economic foundation of the company, allowing for continued investment in patient-centered renal health services across the country.

Abdellah Aitslimane, the Chief Financial Officer & Head of Support Services at Fresenius Kidney Care, directs the integration of financial planning with essential administrative support functions. This role involves streamlining the operational workflows that sustain outpatient dialysis centers, ensuring that facilities remain fully equipped and compliant. By managing the supply chain and procurement processes, the Chief Financial Officer & Head of Support Services reduces overhead costs while maintaining high standards of patient care. Abdellah Aitslimane coordinates with regional managers to ensure that support services align with the broader financial goals of the organization. This leadership position requires constant monitoring of operational efficiency to identify areas for improvement in service delivery. Through the optimization of administrative systems, the Chief Financial Officer & Head of Support Services enhances the overall productivity of the company. This executive leadership ensures that the infrastructure supporting clinical teams remains robust, reliable, and fiscally sound.

Ryan Valle, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) at Fresenius Kidney Care, architects the growth strategy for vascular access services. This role involves overseeing the development of specialized care delivery models that support dialysis patients throughout the United States. By expanding the reach of vascular care, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) ensures that patients receive timely interventions to maintain their access sites. Ryan Valle collaborates with clinical leaders to integrate these services into the existing outpatient network, creating a seamless patient experience. This leadership position focuses on identifying new market opportunities and scaling strategic initiatives to improve clinical outcomes. Through the implementation of advanced vascular procedures, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) drives innovation in renal care. This executive leadership strengthens the company's ability to provide comprehensive, end-to-end health solutions for individuals with kidney disease.

C. Haron, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) at Fresenius Kidney Care, directs the pharmacy operations and regional medical care initiatives. This role involves managing the distribution of specialized medications to dialysis patients, ensuring that pharmaceutical support remains integrated with clinical treatment plans. By overseeing the North American operations, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) ensures that pharmacy services meet the unique needs of the renal patient population. C. Haron coordinates with healthcare providers to optimize medication adherence and improve overall health outcomes. This leadership position requires managing complex logistics and regulatory requirements to maintain high service standards across the continent. Through the strategic development of pharmacy programs, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) enhances the value proposition of the company. This executive leadership ensures that pharmaceutical care remains a core component of the comprehensive renal health services provided by the organization.